Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

IDAS Inhibitors

IDAS inhibitors, or Inhibitors of Differentiation-Associated Sialoglycoprotein, are a class of chemical compounds that interfere with the function of specific glycoproteins associated with cellular differentiation. These inhibitors target sialoglycoproteins, which are a group of glycoproteins containing sialic acid residues attached to their oligosaccharide chains. Sialic acids are key components of glycoproteins that play a role in cell-cell interactions, signaling pathways, and molecular recognition. The precise activity of IDAS inhibitors typically involves modulating these interactions by binding to the sialoglycoproteins or their receptors, thereby altering their normal cellular functions. This modulation can affect the differentiation status of cells, influencing processes such as proliferation, adhesion, and cellular migration. The specificity of IDAS inhibitors to differentiation-associated sialoglycoproteins is critical, as these glycoproteins are often involved in the regulation of cellular states in various biological contexts, such as developmental processes and cellular plasticity.

Structurally, IDAS inhibitors can be diverse, but they often share certain characteristics that enhance their ability to interact with sialoglycoproteins. These compounds may feature functional groups that facilitate binding to the sialic acid residues or mimic their natural ligands, providing the inhibitors with the necessary affinity and specificity. The interactions between IDAS inhibitors and their glycoprotein targets are generally non-covalent, involving hydrogen bonding, van der Waals forces, and hydrophobic interactions, allowing for reversible modulation of the glycoprotein function. The design of IDAS inhibitors often involves understanding the three-dimensional structure of the target glycoproteins and the dynamics of their sialic acid moieties. This structural insight allows for the rational development of inhibitors with optimized binding characteristics. Due to the role of sialoglycoproteins in various cellular pathways, IDAS inhibitors are of great interest in biochemical research, as they provide a tool to dissect the complex processes of cellular differentiation and the role of sialoglycoproteins in cellular regulation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GW4869

6823-69-4sc-218578
sc-218578A
5 mg
25 mg
$199.00
$599.00
24
(3)

Inhibits MCIDAS indirectly by targeting the ceramide pathway. Disrupts ceramide synthesis, influencing membrane lipid composition and impairing the generation of multiciliated cells in respiratory epithelium.

RO-3306

872573-93-8sc-358700
sc-358700A
sc-358700B
1 mg
5 mg
25 mg
$65.00
$160.00
$320.00
37
(1)

Direct inhibitor of CDK1, an interacting partner of MCIDAS. Inhibits CDK1 activity, disrupting the cell cycle progression necessary for multiciliate differentiation and DNA synthesis associated with MCIDAS function.

LY2157299

700874-72-2sc-391123
sc-391123A
5 mg
10 mg
$209.00
$352.00
3
(1)

Targets the TGF-β signaling pathway, influencing MCIDAS indirectly. Inhibits TGF-β receptor, disrupting the downstream signaling events involved in multiciliate differentiation and DNA synthesis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Indirect inhibitor impacting MCIDAS through the PI3K/Akt pathway. Suppresses PI3K, disrupting downstream Akt signaling, leading to impaired multiciliate cell generation and DNA synthesis associated with MCIDAS.

Dovitinib, Free Base

405169-16-6sc-396771
sc-396771A
10 mg
25 mg
$170.00
$350.00
(0)

Targets the JNK pathway, indirectly influencing MCIDAS. Inhibits JNK activity, disrupting the signaling cascade necessary for multiciliate differentiation and DNA synthesis associated with MCIDAS function.

TBB

17374-26-4sc-202830
sc-202830A
sc-202830C
sc-202830B
sc-202830D
10 mg
25 mg
50 mg
100 mg
250 mg
$240.00
$363.00
$445.00
$760.00
$1781.00
17
(1)

Direct inhibitor of CK2, an interacting partner of MCIDAS. Inhibits CK2 activity, disrupting the phosphorylation events crucial for multiciliate differentiation and DNA synthesis associated with MCIDAS function.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$57.00
$184.00
$867.00
10
(1)

Inhibits MCIDAS indirectly through the Wnt pathway. Suppresses GSK-3, disrupting the degradation complex and stabilizing β-catenin, leading to impaired multiciliate cell generation and DNA synthesis associated with MCIDAS.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Targets the SMAD signaling pathway, influencing MCIDAS indirectly. Inhibits the TGF-β type I receptor, disrupting SMAD-mediated events crucial for multiciliate differentiation and DNA synthesis associated with MCIDAS.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

Indirect inhibitor impacting MCIDAS through the Src family kinase pathway. Inhibits Src family kinases, disrupting downstream signaling and impairing multiciliate cell generation and DNA synthesis associated with MCIDAS.

VX-11e

896720-20-0sc-507301
10 mg
$180.00
(0)

Direct inhibitor of HDAC, an interacting partner of MCIDAS. Inhibits HDAC activity, altering chromatin remodeling events necessary for multiciliate differentiation and DNA synthesis associated with MCIDAS function.